Inter Parfums (IPAR) Competitors

Prestige Consumer Healthcare (NYSE:PBH) and Inter Parfums (NASDAQ:IPAR) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, community ranking, profitability, risk, analyst recommendations, dividends and media sentiment.

Which has higher earnings and valuation, PBH or IPAR?

Prestige Consumer Healthcare has higher earnings, but lower revenue than Inter Parfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Inter Parfums, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prestige Consumer Healthcare	$1.13B	3.73	$209.34M	$4.27	19.83
Inter Parfums	$1.32B	3.26	$152.65M	$4.66	28.81

Does the MarketBeat Community prefer PBH or IPAR?

Prestige Consumer Healthcare received 30 more outperform votes than Inter Parfums when rated by MarketBeat users. Likewise, 70.51% of users gave Prestige Consumer Healthcare an outperform vote while only 64.94% of users gave Inter Parfums an outperform vote.

Company	Underperform	Outperform
Prestige Consumer Healthcare	Outperform Votes 495 70.51%	Underperform Votes 207 29.49%
Inter Parfums	Outperform Votes 465 64.94%	Underperform Votes 251 35.06%

Is PBH or IPAR more profitable?

Prestige Consumer Healthcare has a net margin of 19.13% compared to Inter Parfums' net margin of 10.60%. Inter Parfums' return on equity of 16.34% beat Prestige Consumer Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prestige Consumer Healthcare	19.13%	12.36%	6.39%
Inter Parfums	10.60%	16.34%	10.82%

Do analysts recommend PBH or IPAR?

Prestige Consumer Healthcare currently has a consensus price target of $92.60, indicating a potential upside of 9.37%. Inter Parfums has a consensus price target of $159.40, indicating a potential upside of 18.72%. Given Inter Parfums' stronger consensus rating and higher probable upside, analysts clearly believe Inter Parfums is more favorable than Prestige Consumer Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prestige Consumer Healthcare	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
Inter Parfums	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more volatility and risk, PBH or IPAR?

Prestige Consumer Healthcare has a beta of 0.5, indicating that its share price is 50% less volatile than the S&P 500. Comparatively, Inter Parfums has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500.

Does the media prefer PBH or IPAR?

In the previous week, Prestige Consumer Healthcare had 1 more articles in the media than Inter Parfums. MarketBeat recorded 4 mentions for Prestige Consumer Healthcare and 3 mentions for Inter Parfums. Prestige Consumer Healthcare's average media sentiment score of 1.19 beat Inter Parfums' score of 0.90 indicating that Prestige Consumer Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Prestige Consumer Healthcare	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Inter Parfums	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals & insiders hold more shares of PBH or IPAR?

100.0% of Prestige Consumer Healthcare shares are held by institutional investors. Comparatively, 55.6% of Inter Parfums shares are held by institutional investors. 1.6% of Prestige Consumer Healthcare shares are held by insiders. Comparatively, 43.9% of Inter Parfums shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Inter Parfums beats Prestige Consumer Healthcare on 10 of the 18 factors compared between the two stocks.